Diabetes Clinical Trials in Pennsylvania

Showing 261-271 of 271 trials

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

NCT00110864

This study is designed to evaluate the safety and efficacy of PN2034 in insulin-dependent type 2 diabetics as measured by the change in average daily insulin dose from baseline to week 12. The effects of PN2034 on HbA1c, fasting plasma glucose (FPG), and lipid levels will also be measured.

Type 2 Diabetes Mellitus

Wellstat Therapeutics90 participantsStarted May 2005

Waterbury, Connecticut, United States • Hollywood, Florida, United States • Longwood, Florida, United States +15 more locations

COMPLETEDPHASE336 miles

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

NCT00134147

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

Diabetes Mellitus

Pfizer1,100 participantsStarted Apr 2005

La Jolla, California, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +118 more locations

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

Diabetes Trials in Other Cities

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

Other Conditions in Pennsylvania